Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-03 @ 3:17 PM
Study NCT ID:
NCT06729593
Status:
COMPLETED
Last Update Posted:
2025-10-09
First Post:
2024-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
015/ACTIV-3b/H2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None